Tlr4 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Gene Information | |
|---|---|
| Gene Symbol | TLR4 |
| Full Name | Toll-Like Receptor 4 |
| Chromosomal Location | 9q33.1 |
| NCBI Gene ID | 7099 |
| OMIM | 603030 |
| Ensembl ID | ENSG00000136869 |
| UniProt | O00206 |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, ALS, Stroke, Multiple Sclerosis |
TLR4 encodes Toll-Like Receptor 4, a pattern recognition receptor of the innate immune system. TLR4 recognizes pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs), triggering inflammatory responses that play critical roles in neurodegenerative diseases[1].
TLR4 is a type I transmembrane protein belonging to the Toll-like receptor family:
TLR4 is expressed in various cell types:
| Cell Type | Expression | Notes |
|---|---|---|
| Microglia | High | Primary immune cells in brain |
| Astrocytes | Moderate | Also express TLR4 |
| Neurons | Low | May express under stress |
| Endothelial Cells | Moderate | Blood-brain barrier |
| Peripheral Immune Cells | High | Macrophages, monocytes |
| Strategy | Approach | Status | Notes |
|---|---|---|---|
| TLR4 Antagonists | Eritoran, TAK-242 | Clinical Trials | Block TLR4 signaling |
| Anti-inflammatory | Minocycline | Clinical Trials | Reduce TLR4 activation |
| Natural Compounds | Curcumin, resveratrol | Preclinical | Modulate TLR4 pathway |
The study of Tlr4 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4(7):499-511.
[2] Walter S, Letiembre M, Liu Y, et al. Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease. Cell Physiol Biochem. 2007;20(6):947-956.
[3] Drouin-Ouellet J, Cicchetti F. The role of innate immunity in Parkinson's disease: what do we really know? Prog Neuropsychopharmacol Biol Psychiatry. 2014;52:62-70.
[4] Liu Y, Hao W, Letiembre M, et al. Suppression of microglial inflammatory activity by myelin debris. J Neuroinflammation. 2015;12:33.